Form 4 Filing for Cellectar Biosciences, Inc. - Stock Option Grant

This filing details a Form 4 submission for Cellectar Biosciences, Inc. (CLRB) on July 8, 2026. Loren Stefan, acting as a consultant, was granted a stock option to purchase 15,000 shares of common stock at an exercise price of $2.68 per share. The option has an exercise date noted by footnote F1, indicating it will vest in full on July 8, 2027, contingent upon Stefan's continued service. The option expires on July 8, 2036. This transaction is marked as direct ownership. The filing also notes the shares owned following the transaction are 15,000.